project id: TCGA-PAAD; case submitter id: TCGA-3A-A9I5; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.75; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.09; rna integrity number: 7.2; age at index: 57; days to birth: -21175; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1952; age at diagnosis: 21175; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1794.0; icd 10 code: C25.0; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Head of pancreas; synchronous malignancy: No; tissue or organ of origin: Head of pancreas; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: yes; alcohol history: No; is ffpe: false; composition: Not Reported; days to collection: 1492; days to sample procurement: 0; initial weight: 60.0; portion submitter id: TCGA-3A-A9I5-01A-11; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 0.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0;